BRIEF published on 06/18/2026 at 07:35, 2 months 29 days ago ABIONYX Pharma Completes Successful EUR 33 Million Financing Capital Increase Bond Financing ABIONYX Pharma Fenja Capital Sepsis Research
PRESS RELEASE published on 06/18/2026 at 07:30, 2 months 29 days ago Inside Information / Other news releases ABIONYX Pharma successfully completes financing, raising EUR 33 M. Capital increase and bonds financing secured, enhancing financial position for future growth and clinical trials Financing Clinical Trials Capital Increase ABIONYX Pharma Bonds Financing
BRIEF published on 05/28/2026 at 19:11, 3 months 19 days ago ABIONYX Pharma: Review of the first quarter of 2026 Revenue Treasury Funding Innovative Therapies Sepsis
BRIEF published on 05/28/2026 at 19:11, 3 months 19 days ago ABIONYX Pharma Reports Stable First Quarter and Robust Financing for Future Growth Clinical Trials Capital Increase Financial Stability ABIONYX Pharma Revenue 2026
PRESS RELEASE published on 05/28/2026 at 19:06, 3 months 19 days ago Inside Information / Other news releases ABIONYX Pharma updates its operations and cash position for Q1 2026. Consolidated revenue of €0.8M, cash reserves of €2.8M. Funding secured till 2028 through capital increase and non-dilutive loan Revenue Cash Position Funding ABIONYX Pharma Q1 2026
PRESS RELEASE published on 05/27/2026 at 07:30, 3 months 21 days ago Inside Information / Other news releases ABIONYX Pharma launches a fully secured capital increase with preferential subscription rights and structured debt financing for up to EUR 33M. Finnja Capital commits EUR 10M in a non-dilutive loan Capital Increase Preferential Subscription Rights ABIONYX Pharma Fenja Capital Structured Debt Financing
BRIEF published on 04/08/2026 at 23:59, 5 months 8 days ago ABIONYX Reports Share Capital and Voting Rights Details Euronext Paris Share Capital Voting Rights Financial Disclosure ABIONYX
PRESS RELEASE published on 04/08/2026 at 23:54, 5 months 8 days ago Inside Information / Other news releases ABIONYX Pharma releases monthly statement of total voting rights and shares for March 31, 2026, in accordance with French regulations Shares French Regulations Total Voting Rights Biotech Company ABIONYX Pharma
BRIEF published on 03/17/2026 at 19:31, 5 months 30 days ago ABIONYX Pharma makes available the 2025 Universal Registration Document AMF Biopharmaceutical Registration Document ABIONYX Pharma Sepsis
PRESS RELEASE published on 03/17/2026 at 19:26, 5 months 30 days ago Inside Information / Other news releases ABIONYX Pharma announces the availability of its Universal Registration Document for the year 2025, filed with the AMF and accessible on their website AMF Biopharmaceutical Universal Registration Document ABIONYX Pharma Sepsis
Published on 09/17/2026 at 10:00, 1 hour 26 minutes ago Eagle Plains Reports Additional Results from Drilling at the Don Lake Uranium Project, Saskatchewan
Published on 09/16/2026 at 23:45, 11 hours 41 minutes ago Galway Metals Settles Claim by Former Employee with Cash and Share Payments
Published on 09/16/2026 at 21:30, 13 hours 56 minutes ago Torq Completes $1.7 Million Private Placement
Published on 09/16/2026 at 16:55, 18 hours 31 minutes ago CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 15:00, 20 hours 26 minutes ago 2026 Canada's Top 40 Under 40(R) Honourees Announced
Published on 09/17/2026 at 11:00, 26 minutes ago ABB Ltd: ABB share buybacks - September 10, 2026 - September 16, 2026
Published on 09/17/2026 at 10:41, 45 minutes ago elumeo SE successfully completes a cash capital increase
Published on 09/17/2026 at 10:40, 46 minutes ago Making the Most of Every Ray, Powering the Unpowered: 2026 Global Low-Carbon Industry Forum Explores Pathways to Bridge the Electricity Gap
Published on 09/17/2026 at 10:05, 1 hour 20 minutes ago Geely Farizon Debuts Full-Spectrum Electric Commercial Vehicle Lineup at IAA Transportation 2026
Published on 09/17/2026 at 10:05, 1 hour 20 minutes ago Avalara Appoints Claire Goad as General Manager of E-Invoicing and Live Reporting
Published on 09/16/2026 at 17:45, 17 hours 41 minutes ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 4 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 17 hours ago Report on the Combined General Meeting of the 10th of September 2026
